AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (1.3 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer

Ruoqing Wang1,2, Shuhao Jiang1,2, Qun Zhang1,2, Junjie Li1,2 ( )
Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 23 Issue 9,
September 2026
Pages 1205-1212
DOI: 10.20892/j.issn.2095-3941.2026.0277

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Wang R, Jiang S, Zhang Q, et al. The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer. Cancer Biology & Medicine, 2026, 23(9): 1205-1212. https://doi.org/10.20892/j.issn.2095-3941.2026.0277

9

Views

2

Downloads

0

Crossref

0

Web of Science

0

Scopus
Received: 03 April 2026
Accepted: 09 June 2026
Published: 13 July 2026
©2026 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)